[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:meniere-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":43,"states":44},"Meniere Disease",5,3,[8,16,23,29,36],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05582837","Treatment of Meniere's Disease With Migraine Medications",[12],"Phase 4","RECRUITING","2026-08-26T02:19:08.862440Z","2026-05-05T02:43:28.104268Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT03587701","Effects of Anakinra in Subjects With Corticosteroid-resistant\u002FIntolerant Meniere's Disease and Autoimmune Inner Ear Disease",[20],"Phase 2","2026-08-26T02:15:57.572488Z","2026-04-29T02:57:57.120569Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04806282","Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets",[],"2026-08-26T02:18:38.865010Z","2026-05-29T15:36:40.161483Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT03795675","CI Following VS Removal or Labyrinthectomy",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:18:16.987470Z","2026-05-05T02:43:29.068657Z",{"nct_id":37,"title":38,"phases":39,"status":33,"updated_at":41,"content_modified":42},"NCT06859788","SPI-1005 for the Treatment of Meniere's Disease (Open Label)",[40],"Phase 3","2026-08-03T02:52:31.195166Z","2026-05-05T02:43:26.685144Z",[],[]]